Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
HRAS G13R
i
Other names:
HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3265
Related biomarkers:
Expression
Mutation
Others
‹
HRAS overexpression (2)
HRAS overexpression (2)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
HRAS G13R
Urothelial Cancer
HRAS G13R
Urothelial Cancer
tipifarnib
Sensitive: C3 – Early Trials
tipifarnib
Sensitive
:
C3
tipifarnib
Sensitive: C3 – Early Trials
tipifarnib
Sensitive
:
C3
HRAS G13R
Squamous Cell Carcinoma of Head and Neck
HRAS G13R
Squamous Cell Carcinoma of Head and Neck
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
FRAX597
Sensitive: D – Preclinical
FRAX597
Sensitive
:
D
FRAX597
Sensitive: D – Preclinical
FRAX597
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
trametinib + dasatinib
Sensitive: D – Preclinical
trametinib + dasatinib
Sensitive
:
D
trametinib + dasatinib
Sensitive: D – Preclinical
trametinib + dasatinib
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
dasatinib + SCH772984
Sensitive: D – Preclinical
dasatinib + SCH772984
Sensitive
:
D
dasatinib + SCH772984
Sensitive: D – Preclinical
dasatinib + SCH772984
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
dasatinib + selumetinib
Sensitive: D – Preclinical
dasatinib + selumetinib
Sensitive
:
D
dasatinib + selumetinib
Sensitive: D – Preclinical
dasatinib + selumetinib
Sensitive
:
D
HRAS G13R
Thyroid Gland Carcinoma
HRAS G13R
Thyroid Gland Carcinoma
selumetinib
Sensitive: D – Preclinical
selumetinib
Sensitive
:
D
selumetinib
Sensitive: D – Preclinical
selumetinib
Sensitive
:
D
HRAS G13R
Thyroid Gland Anaplastic Carcinoma
HRAS G13R
Thyroid Gland Anaplastic Carcinoma
CI-1040
Sensitive: D – Preclinical
CI-1040
Sensitive
:
D
CI-1040
Sensitive: D – Preclinical
CI-1040
Sensitive
:
D
HRAS G13R
Solid Tumor
HRAS G13R
Solid Tumor
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login